Hepatic immune cells in non-metastatic colorectal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031113

Enrollment

Registered

2023-05-02

Start date

2023-06-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C18

Interventions

Group 1: Patients non-metastatic colorectal cancer

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Patients undergoing surgery for primary colorectal cancer. 2. Age = 18 years. 3. Informed consent. 4. Available preoperative cross sectional imaging for sarcopenia measurement

Exclusion criteria

Exclusion criteria: 1. Any factors compromising the capability to cooperate or follow study protocol (e.g. impaired cognitive function or active drug abuse)

Design outcomes

Primary

Measure	Time frame
Quantity, quality and activation status of hepatic immune cells	—

Secondary

Measure	Time frame
Sarcopenia in non-metastatic colorectal cancer	—

Countries

Germany

Contacts

Public ContactUlf Peter Neumann

Klinik für Allg., Viszeral- und Transplantationschirurgie, Uniklinik RWTH Aachen

chirurgie@ukaachen.de+49 241 80 89500

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026